Stocks · Health care · Pharmaceutical Preparations

Edgewise Therapeutics, Inc.

EWTX Clue Score35

United States Fiscal year ends December CIK 0001710072 Results filed 4 Nov 2026

Add to watchlist

What the insiders did Mostly scheduled

Bought (12 mo)

$199.40K

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$19.50M

$506.73K on a plan · $18.71M straight out of an exercise

Sold at will

$290.37K

2 of 33 sales

Net

−$19.30M

−$90.96K against sales at will